✦ LIBER ✦

Frequent loss of BRCA1 mRNA and protein expression in sporadic ovarian cancers

✍ Scribed by Paul A. Russell; Paul D.P. Pharoah; Karen De Foy; Susan J. Ramus; Ian Symmonds; Annie Wilson; Ian Scott; Bruce A.J. Ponder; Simon A. Gayther

Publisher: John Wiley and Sons
Year: 2000
Tongue: French
Weight: 307 KB
Volume: 87
Category: Article
ISSN: 0020-7136
DOI: 10.1002/1097-0215(20000801)87:3<317::aid-ijc2>3.0.co;2-b

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Preferential allelic expression can lead

Preferential allelic expression can lead to reduced expression of BRCA1 in sporadic breast cancers

✍ Hilmi Özçelik; Minh D. To; Jean Couture; Shelley B. Bull; Irene L. Andrulis 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 French ⚖ 101 KB 👁 2 views

BRCA1 is considered to be a tumor-suppressor gene, yet mutations in this gene are uncommon in sporadic breast tumors. We investigated whether mechanisms other than DNA mutations that affect the coding region might be involved in breast carcinogenesis. Since loss of expression of the BRCA1 gene would

Immunohistochemical expression of BRCA2

Immunohistochemical expression of BRCA2 protein and allelic loss at the BRCA2 locus in prostate cancer

✍ Stephen M. Edwards; William D. Dunsmuir; Cheryl E. Gillett; Sunil R. Lakhani; Ca 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 French ⚖ 370 KB 👁 2 views

Association between loss of heterozygosi

Association between loss of heterozygosity of BRCA1 and BRCA2 and morphological attributes of sporadic breast cancer

✍ Andrew M. Hanby; David P. Kelsell; Henry W. Potts; Cheryl E. Gillett; D. Timothy 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 French ⚖ 61 KB 👁 2 views

Quantification of BRCA1 protein in spora

Quantification of BRCA1 protein in sporadic breast carcinoma with or without loss of heterozygosity of the BRCA1 gene

✍ Pascale G. Rio; Jean-Claude Maurizis; Monique Peffault de Latour; Yves-Jean Bign 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 French ⚖ 50 KB 👁 2 views

Identification of missense and truncatin

Identification of missense and truncating mutations in the BRCA1 gene in sporadic and familial breast and ovarian cancer

✍ Jill Greenman; Shehla Mohammed; David Ellis; Sally Watts; Gillian Scott; Louise 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 58 KB 👁 2 views

The cloning of the breast and ovarian cancer susceptibility gene, BRCA1, allows direct estimation of the proportion of these cancers in the general population which can be attributed to germline mutations in this gene. We have used a combination of SSCP, heteroduplex analysis, and chemical cleavage

Prevalence of founder BRCA1 and BRCA2 mu

Prevalence of founder BRCA1 and BRCA2 mutations among breast and ovarian cancer patients in hungary

✍ Marco Van der Looij; Csilla Szabo; Istvan Besznyak; Gyorgy Liszka; Bela Csokay; 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 French ⚖ 55 KB 👁 2 views

We have investigated the impact of BRACA1 and BRACA2 mutations that were frequently identified among Hungarian high-risk breast-ovarian cancer families (Ramus et al., 1997b, AJHG), on the development of breast and ovarian cancer in the general Hungarian population. The prevalence of 3 BRCA1 mutation